Search Results

Takayasu’s arteritis

Tertiary prevention

Title 1 Oxford Textbook of Medicine SIXTH EDITION Volume 4: Sections 22–30 EDITED BY John D. Firth Christopher P. Conlon Timothy M. Cox

Treatment section 21  Disorders of the kidney and urinary tract 4994 The haemorrhagic risks of renal biopsy are increased by ur- aemia, anticoagulation, and clotting factor deficiency after plasma exchange. Renal biopsy should not be considered essential when ...

UAER section 21  Disorders of the kidney and urinary tract 4982 increased albuminuria. Accurate data on GFR are not given in many of these studies, but in type 1 patients, long-​term ACE inhibitor therapy appears to stabilize renal function after an initial re...

Urinary tract obstruction 5124 Muhammad M. Yaqoob and Kieran McCafferty

Why does intensive glycaemic control fail to completelyprevent development of moderately increasedalbuminuria?

cover 2 ONLY FOR SALE IN INDIA, BANGLADESH, SRI LANKA, NEPAL, BHUTAN, AND MYANMAR AND NOT FOR EXPORT THEREFROM. NOT FOR SALE IN ANY OTHER COUNTRY IN THE WORLD SIXTH EDITION VOLUME 4 edited by John D. Firth Christopher P. Conlon Timothy M. Cox Oxford Textbook o...

22.1 Introduction to haematology 5169 Chris Hatton ESSENTIALS Haematology is the study of the composition, function, and diseases of the blood. The approach to a patient suspected of having a haematological disorder begins with taking a history (particularly n...

22.2 Haematopoiesis 5172 22.2.1 Cellular and molecular basis of haematopoiesis 5172 Paresh Vyas and N. Asger Jakobsen CONTENTS 22.2.1 Cellular and molecular basis of haematopoiesis  5172 Paresh Vyas and N. Asger Jakobsen 22.2.2 Diagnostic techniques in the a...

22.2.2 Diagnostic techniques in the assessment of haematological malignancies 5181 Wendy N. Erber 22.2.2  Diagnostic techniques in the assessment of haematological malignancies 5181 and retention of maturing haematopoietic cells within the marrow as shown by t...

22.3 Myeloid disease 5189 22.3.1 Granulocytes in health and disease 5189 Joseph Sinning and Nancy Berliner CONTENTS 22.3.1 Granulocytes in health and disease  5189 Joseph Sinning and Nancy Berliner 22.3.2 Myelodysplastic syndromes  5197 Charlotte K. Brierley...

22.3.2 Myelodysplastic syndromes 5197 Charlotte K. Brierley and David P. Steensma 22.3.2  Myelodysplastic syndromes 5197 for neutrophils and eosinophils, leukotrienes, prostaglandins, and platelet-​activating factor. They arise in the marrow from the same myel...

22.3.3 Acute myeloid leukaemia 5205 Nigel Russell and Alan Burnett 22.3.3  Acute myeloid leukaemia 5205 Greenberg PL, et al. (2012). Revised international prognostic scoring system for myelodysplastic syndromes. Blood, 120, 2454–​65. Haferlach T, et al. (2014)...

22.3.4 Chronic myeloid leukaemia 5213 Mhairi Copland and Tessa L. Holyoake† 22.3.4  Chronic myeloid leukaemia 5213 22.3.4  Chronic myeloid leukaemia Mhairi Copland and Tessa L. Holyoake† ESSENTIALS Chronic myeloid leukaemia (CML) has a worldwide incidence of 1...

22.3.5 The polycythaemias 5227 Daniel Aruch and Ronald Hoffman 22.3.5  The polycythaemias 5227 Latif A-​L, et al. (2013). Allogeneic stem cell transplantation for Chronic Myeloid Leukemia is safe and effective in high risk patients fol- lowing second generatio...

22.3.6 Thrombocytosis and essential thrombocythaemia 5239 Daniel Aruch and Ronald Hoffman 22.3.6  Thrombocytosis and essential thrombocythaemia 5239 FURTHER READING Arber DA, et  al. (2016). The 2016 revision to the World Health Organization (WHO) classificati...

22.3.7 Primary myelofibrosis 5247 Evan M. Braunstein and Jerry L. Spivak 22.3.7  Primary myelofibrosis 5247 Karow A, et  al. (2015). Mutational profile of childhood myeloproliferative neoplasms. Leukemia, 29, 2407–​9. Kaushansky K (2005). The molecular mechani...